The Addition at Day 9 of Hd-MTX to the (Da)-Epoch Scheme With or Without Rituximab Is an Effective Regimen in Untreated Advanced Stage High Risk Lymphoma: A Feasibility Study

Hematological Oncology - United Kingdom
doi 10.1002/hon.117_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Immunochemotherapy With Obinutuzumab or Rituximab in Previously Untreated Follicular Lymphoma in the Randomised Phase Iii Gallium Study: Analysis by Chemotherapy Regimen

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

High-Dose Methotrexate With or Without Rituximab in Newly Diagnosed Primary CNS Lymphoma

Neurology
Neurology
2014English

T(11;18)(q21;q21)-Positive Advanced-Stage MALT Lymphoma Associated With Monoclonal Gammopathy : Resistance to Rituximab or Rituximab-Containing Chemotherapy

Journal of clinical and experimental hematopathology : JCEH
Medicine
2008English

Ebeacopp With or Without Rituximab in Interim-Pet-Positive Advanced-Stage Hodgkin Lymphoma: Updated Results of the International, Randomized Phase 3 GHSG Hd18 Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Rituximab Plus Lenalidomide Is as Effective as Immunochemotherapy in the Eradication of Molecular Disease in Untreated Follicular Lymphoma: Relevance Lysa Ancillary Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Da-Epoch-R Versus R-Chop in High Risk DLBCL Patients: Analysis of the Czech Lymphoma Study Group (Clsg)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Differences in Quality of Life Between Bendamustine-Rituximab and R-Chop/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2016English

Correction To: White Matter Changes in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate With or Without Rituximab

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2019English

The Glasgow Prognostic Score at Diagnosis Is an Independent Predictor of Survival in Advanced Stage Classical Hodgkin Lymphoma

British Journal of Haematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy